PILOT INTERGROUP STUDY OF HIGH-DOSE CISPLATIN, ETOPOSIDE AND BLEOMYCIN (HD-PEB) COMBINED WITH AMIFOSTINE IN CHILDREN WITH HIGH-RISK MALIGNANT GERM CELL TUMORS